Résultats et enseignements d’une stratégie innovante de prise en charge des nausées et vomissements chimio-induits
| Autor: | M. Paillet, Hervé Rimlinger, Marc Hervouet, David Le Breton, Fabien Vaylet, Sacha Bédrossian, G. Camus, Stéphanie Reignier, Hervé Le Floch, Xavier Bohand, Morgane Guillaudin, Jacques Margery, Frédéric Rivière, Vincent Jandard |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Cancer Research
Chemotherapy medicine.medical_specialty business.industry Nausea medicine.drug_class medicine.medical_treatment Hematology General Medicine Oncology medicine Vomiting Antiemetic Anxiety Radiology Nuclear Medicine and imaging Personalized medicine medicine.symptom Risk assessment business Intensive care medicine Prospective cohort study |
| Zdroj: | Bulletin du Cancer. 100:799-810 |
| ISSN: | 0007-4551 |
| DOI: | 10.1684/bdc.2013.1797 |
| Popis: | Current chemotherapy-induced nausea and vomiting management guidelines recommend taking into account the emetogenic potential of the chemotherapy employed as well as individual risk factors to such effects. We performed an interventional prospective study to assess the impact of an innovating therapeutic optimization strategy. The latter combines current guidelines application to a specific consultation in order to individualize the treatment. This study included 170 patients and covered a total of 1,746 days of various chemotherapies. Among these patients, 86.5% never vomited and 53.8% never had any nausea or vomiting. These results seem generally better than the ones found in the literature with all kinds of chemotherapies. Regarding them, we have attempted to highlight the determining criteria for a successful antiemetic treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|